Browse the evidence

Gut microbiota-derived succinate acts as a signaling metabolite that regulates host energy metabolism and immune function via the SUCNR1 receptor, with effects ranging from beneficial metabolic improvements to pathological inflammation depending on context and receptor signaling integrity.

Focus on dietary fiber and diverse plant foods to support a healthy gut microbiome that produces balanced succinate levels. Avoid excessive processed foods that may cause dysbiosis. While succinate itself is not a direct supplement, its production by beneficial bacteria (like Prevotella) is linked to improved glucose metabolism.

Irisin has anti-inflammatory properties in adipose tissue, suppressing pro-inflammatory cytokines and promoting the switching of macrophages from a pro-inflammatory (M1) to an anti-inflammatory (M2) state.

Managing obesity reduces systemic inflammation. While irisin contributes to this anti-inflammatory effect, the primary benefit comes from overall weight loss and exercise, not from targeting inflammation via irisin alone.

Maternal health factors during pregnancy, specifically high BMI and diet, influence the infant's gut microbiota composition and long-term vulnerability to obesity and diabetes.

A mother's health and diet during pregnancy can shape her baby's gut bacteria and long-term metabolic health. Maintaining a healthy weight and diet during pregnancy may support a favorable microbiome for the developing fetus.

Faecal microbiota transplantation (FMT) using autologous stool preserves stimulated C-peptide levels (residual beta-cell function) in patients with new-onset type 1 diabetes over 12 months, whereas allogenic (healthy donor) FMT does not.

For individuals with very recent-onset Type 1 Diabetes, using their own gut bacteria (autologous FMT) may help preserve remaining insulin production, whereas using healthy donor bacteria does not offer this benefit. This is a specialized medical intervention, not a DIY protocol.

Fermentation of non-starch polysaccharides by colonic microflora produces short-chain fatty acids (SCFAs), particularly butyrate, which promotes large bowel health, inhibits pathogenic organisms, and may offer a prebiotic effect.

Include a variety of fibrous plant foods in your diet to feed your gut bacteria. These bacteria ferment the fiber into beneficial compounds like butyrate, which support colon health and may help protect against colorectal issues.

Chronic exposure to an obesogenic diet induces low-grade systemic inflammation that causes loss of muscle integrity (intramuscular lipid accumulation, fibrosis, and reduced satellite cell function), which acts as a central driver for musculoskeletal diseases including osteoarthritis, tendinopathy, and osteoporosis.

If you have obesity and joint/muscle pain, weight loss alone may not restore function because the underlying muscle tissue may be damaged by inflammation (fat infiltration, fibrosis). Focus on preserving or rebuilding muscle quality through resistance training and anti-inflammatory dietary patterns, not just weight reduction, as muscle integrity appears to be the key to preventing musculoskeletal disease.

Childhood stunting and low birth weight are associated with an increased risk of obesity and metabolic complications later in life, particularly in Asian populations.

Ensure adequate nutrition during pregnancy and early childhood to prevent stunting, which is a risk factor for obesity and metabolic disease later in life.

Milk products have a low glycaemic index (GI) but a high insulinaemic index (II), meaning they elicit an insulin response similar to white bread despite low blood glucose impact.

Be aware that while milk has a low glycaemic index, it can still stimulate a significant insulin response. This is due to milk proteins, not lactose. For most people, this is not a concern, but those monitoring insulin levels should be aware of this discrepancy.

Activation of the Nrf2/Keap1/ARE pathway improves insulin sensitivity, reduces hyperglycemia, and protects pancreatic beta-cells in type II diabetes models, whereas classic direct antioxidants have failed to show benefit.

Focus on lifestyle and dietary choices that naturally support your body's antioxidant defenses (like the Nrf2 pathway) rather than relying on high-dose direct antioxidant supplements. The paper highlights that compounds like sulforaphane (found in cruciferous vegetables) and resveratrol (found in grapes/berries) may help activate this pathway, potentially improving insulin sensitivity and protecting cells, whereas direct antioxidant supplements have not shown clinical benefit for diabetic complications.

Intermittent fasting lowers blood pressure through increased parasympathetic activity mediated by Brain-Derived Neurotrophic Factor (BDNF), leading to reduced heart rate and blood pressure.

If you have high blood pressure, intermittent fasting might help lower it by calming your nervous system (increasing parasympathetic tone). However, this effect is not guaranteed for everyone, and you should monitor your BP. Do not stop prescribed blood pressure medication without consulting your doctor.

Saturated fatty acids activate Toll-like receptors (TLR2 and TLR4) on immune and adipose cells, triggering proinflammatory cytokine production (TNF-α, IL-6) and contributing to insulin resistance, whereas unsaturated fatty acids inhibit this signaling.

Dietary fat quality matters for inflammation. Saturated fats can trigger immune receptors (TLRs) that promote inflammation and insulin resistance, while unsaturated fats (like those in fish oil) can block this pathway. Prioritize unsaturated fats to mitigate inflammatory signaling.

TLR4 deficiency protects mice from diet-induced obesity and improves insulin sensitivity, although effects on body weight are contradictory across studies.

Immune system activation via Toll-like receptors (specifically TLR4) by dietary saturated fats may drive insulin resistance and inflammation associated with obesity. While genetic modification of TLR4 shows benefits in mice, this highlights the importance of managing saturated fat intake to reduce inflammatory signaling.

Leg fat (appendicular fat) is inversely related to insulin resistance, suggesting that fat storage in the legs may be metabolically protective compared to trunk or liver fat.

Fat stored in the legs may be less harmful to metabolic health than fat stored in the liver or abdomen. While overall weight management is important, the location of fat storage is a key determinant of metabolic risk.

Short-term cold acclimation (10 days of intermittent exposure to 14-15°C) recruits brown adipose tissue (BAT) and enhances skeletal muscle glucose uptake in metabolically healthy obese men.

If you are obese, exposing yourself to mild cold (around 14-15°C or 57-59°F) for 10 days can help your body recruit brown fat and improve how your muscles handle glucose. Start with short exposures (2 hours) and gradually increase to 6 hours per day. You don't need to be freezing; just cool enough to trigger a response without shivering excessively. This adaptation may help counteract some metabolic risks associated with obesity.

Cold acclimation enhances basal GLUT4 translocation to the sarcolemma in skeletal muscle of obese men, facilitating increased glucose uptake.

Cold exposure not only activates brown fat but also improves your muscles' ability to take up glucose by moving glucose transporters (GLUT4) to the cell surface. This happens even in obese individuals and may help maintain better blood sugar control.

Obesity-associated gut dysbiosis contributes to cognitive and mood deficits through the activation of the HPA-axis, leading to glucocorticoid overproduction, and the promotion of a pro-inflammatory milieu (endotoxemia/leaky gut) that causes neuro-inflammation.

If you are obese and experiencing brain fog or mood issues, your gut health may be a contributing factor, not just your weight. The paper suggests that improving diet (fiber, prebiotics) or using specific probiotics might help restore gut balance, reduce inflammation, and lower stress hormones, potentially improving cognitive and emotional health. This is not a cure-all, but a modifiable lever.

Hyperinsulinemia is the primary etiological driver of insulin resistance, obesity, type 2 diabetes, and cardiovascular disease, rather than a compensatory response to insulin resistance.

Focus on lowering baseline insulin levels through dietary changes (e.g., reducing refined carbohydrates and sugars) and increasing hepatic insulin clearance. This may prevent or reverse the progression to insulin resistance, obesity, and type 2 diabetes, as high insulin is the primary driver of these conditions.

Hyperinsulinemia shifts the insulin-to-GH ratio towards insulin, suppressing Growth Hormone and IGF-I, which promotes fat accumulation and reduces energy expenditure.

Reducing insulin levels may restore the natural balance with Growth Hormone, potentially improving lipid breakdown and energy expenditure, aiding in obesity management.

Normal physiological levels of ceramide are necessary for glucose homeostasis; inhibiting ceramide synthesis in lean mice causes glucose intolerance and insulin resistance.

While blocking ceramide helps obese mice, it can harm lean mice by causing insulin resistance, suggesting a 'Goldilocks' zone for ceramide levels.

GLP-1 analogs improve skeletal muscle glucose metabolism and glycogen synthesis through non-canonical signaling pathways independent of cAMP.

GLP-1 analogs may help your muscles use glucose more efficiently through a separate pathway than in the pancreas. This contributes to better blood sugar control and energy storage as glycogen.

GLP-1-based therapies (GLP-1 receptor agonists and DPP-4 inhibitors) are associated with a class-wide risk of acute pancreatitis, driven by a mechanism of supraphysiological GLP-1 receptor activation causing exocrine pancreatic duct proliferation and potential occlusion.

If you are taking a GLP-1 drug (like Ozempic, Trulicity, or Victoza) or a DPP-4 inhibitor (like Januvia), be aware of the potential risk of pancreatitis. If you experience severe, persistent abdominal pain, stop the medication and seek medical attention immediately. The paper suggests this risk is real and mechanistically plausible, not just a rare side effect.

GLP-1-based therapies are associated with an increased risk of thyroid cancer, specifically medullary thyroid cancer and papillary thyroid cancer, due to GLP-1 receptor expression in thyroid C-cells and papillary cancer cells.

If you are taking a GLP-1 drug, be aware of the potential risk of thyroid cancer. If you notice a lump in your neck, hoarseness, or difficulty swallowing, seek medical attention immediately. The paper suggests this risk is real and mechanistically plausible, not just a rare side effect.

Calorie restriction reduces oxidative damage to macromolecules (DNA, proteins, lipids) and down-regulates the insulin/IGF-1/mTOR signaling pathways, which are key mechanisms for extending healthspan and lifespan.

While CR reduces oxidative stress and IGF-1 signaling, these are downstream effects of the metabolic state. You cannot simply take antioxidant supplements to achieve these benefits; the hormonal and metabolic shifts require actual caloric restriction.

Fetal undernutrition programs metabolic efficiency that becomes maladaptive in overnourished environments, leading to abnormal lipid profiles, altered glucose/insulin metabolism, and obesity.

Early life nutrition (fetal and infant) can program metabolic efficiency that predisposes individuals to obesity and diabetes if they later consume an overnourished diet. Public health should consider early life interventions.